Why the study?
Cardiovascular disease diagnosis in women remains challenging due to knowledge gaps regarding sex differences and the historical underrepresentation of women in cardiovascular research.
What is the diagnostic and prognostic value of cardiac magnetic resonance imaging compared to alternative imaging modalities in women with cardiovascular disorders?
What is the diagnostic and prognostic value of cardiac magnetic resonance imaging compared to alternative imaging modalities in women with cardiovascular disorders?
Cardiac MR offers added diagnostic and prognostic value over alternative imaging modalities for evaluating cardiomyopathies and other cardiovascular disorders in women.
May inform sex-specific imaging decisions in women; leaves open need for prospective validation before practice change.
The diagnosis of cardiovascular disease in women poses an ongoing challenge due to lack of knowledge about sex differences in the manifestations of cardiovascular disease, since women have been underrepresented in cardiovascular research studies that guide current practice. The purpose of this article is to review a spectrum of cardiovascular disorders which occur exclusively or more frequently in women and to highlight the role that cardiovascular magnetic resonance (MR) plays in diagnosing and prognosticating these disorders. Specifically, this review focuses on cardio-oncologic, ischemic, inflammatory, autoimmune, peri-partum, and genetic manifestations of cardiomyopathy in women. We strive to draw attention to the added diagnostic value provided by cardiac MR, compared against alternative imaging modalities, and propose opportunities for further research on sex differences in imaging and diagnosing cardiovascular diseases. EVIDENCE LEVEL: 1 TECHNICAL EFFICACY: Stage 3.
No takes yet. Share an insight, caveat, or question.
Diaz et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: